The fate of drug discovery in academia: Why is it so difficult?
A new editorial paper titled "The fate of drug discovery in academia; dumping in the publication landfill?" has been published in Oncotarget.
Feb 5, 2024
0
0
A new editorial paper titled "The fate of drug discovery in academia; dumping in the publication landfill?" has been published in Oncotarget.
Feb 5, 2024
0
0
The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park Comprehensive Cancer Center, as a possible treatment for pancreatic ...
Feb 5, 2024
0
0
Researchers from Rutgers believe themselves among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—the antiviral medication that helps keep high-risk patients out of the hospital ...
Jan 9, 2024
0
15
The chikungunya virus is widespread in tropical regions, where it is spread to humans by mosquitoes of the genus Aedes. Chikungunya is characterized by high fever, headache, muscle and joint pain, rash, and sometimes diarrhea. ...
Nov 22, 2023
0
0
The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.
Nov 3, 2023
0
1
A new drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in ...
Oct 26, 2023
0
0
Neuroblastomas are tumors of the nervous system. They can form in many places in the body and are the most common cause of cancer-related deaths in young children. A team of researchers at University Medicine Halle has discovered ...
Aug 25, 2023
0
28
A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates—bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing ...
Apr 10, 2023
0
190
A new study published in OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates ...
Mar 27, 2023
0
6
The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study publishing March 2nd in the open access journal PLoS Biology ...
Mar 2, 2023
0
53